Could a simple home sensor reveal how a Vitamin-Like supplement affects Alzheimer's?

NCT ID NCT05245903

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a radio-wave sensor placed in the home can measure sleep, movement, and walking speed in 40 people with mild cognitive impairment or mild Alzheimer's who are taking nicotinamide riboside (a form of vitamin B3). The goal is to find digital biomarkers that reflect changes in brain energy metabolism. The study does not test whether the supplement improves symptoms, but rather how well the sensor can track potential effects.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
nicotinamide riboside
What this could lead to
If successful, this could help identify digital biomarkers that track brain energy changes, potentially guiding future treatments for cognitive decline.
What could go wrong
This is a small, early-stage study focused on measuring outcomes, not testing effectiveness. The sensor technology may not reliably capture meaningful changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • McLean Hospital

    RECRUITING

    Belmont, Massachusetts, 02478, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.